121 related articles for article (PubMed ID: 7910660)
1. Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea.
Sosinski J; Thakar JH; Germain GS; Dias P; Harwood FC; Kuttesch JF; Houghton PJ
Mol Pharmacol; 1994 May; 45(5):962-70. PubMed ID: 7910660
[TBL] [Abstract][Full Text] [Related]
2. Separation of resistance to antitumor diarylsulfonylurea agents from collateral sensitivity to mitochondrial toxins.
Shu LL; Houghton PJ
Mol Pharmacol; 1996 Apr; 49(4):595-601. PubMed ID: 8609886
[TBL] [Abstract][Full Text] [Related]
3. Proliferation-dependent and -independent cytotoxicity by antitumor diarylsulfonylureas. Indication of multiple mechanisms of drug action.
Sosinski J; Thakar JH; Germain GS; Harwood FC; Houghton PJ
Biochem Pharmacol; 1993 May; 45(10):2135-42. PubMed ID: 8512595
[TBL] [Abstract][Full Text] [Related]
4. Effect of antitumor diarylsulfonylureas on in vivo and in vitro mitochondrial structure and functions.
Thakar JH; Chapin C; Berg RH; Ashmun RA; Houghton PJ
Cancer Res; 1991 Dec; 51(23 Pt 1):6286-91. PubMed ID: 1933889
[TBL] [Abstract][Full Text] [Related]
5. N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea, a novel agent equally cytotoxic to nonproliferating human colon adenocarcinoma cells.
Houghton PJ; Bailey FC; Germain GS; Grindey GB; Witt BC; Houghton JA
Cancer Res; 1990 Jan; 50(2):318-22. PubMed ID: 2295071
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the intracellular distribution and binding in human adenocarcinoma cells of N-(4-azidophenylsulfonyl)-N'-(4-chlorophenyl)urea (LY219703), a photoaffinity analogue of the antitumor diarylsulfonylurea sulofenur.
Houghton PJ; Sosinski J; Thakar JH; Boder GB; Grindey GB
Biochem Pharmacol; 1995 Mar; 49(5):661-8. PubMed ID: 7887981
[TBL] [Abstract][Full Text] [Related]
7. Evidence for mitochondrial localization of N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl)urea in human colon adenocarcinoma cells.
Houghton PJ; Bailey FC; Houghton JA; Murti KG; Howbert JJ; Grindey GB
Cancer Res; 1990 Feb; 50(3):664-8. PubMed ID: 2297707
[TBL] [Abstract][Full Text] [Related]
8. Effect of albumin on antitumor activity of diarylsulfonylureas.
Schultz RM; Andis SL; Toth JE; Boder GB; Rinzel SM; Grindey GB
Anticancer Res; 1993; 13(6A):1939-43. PubMed ID: 8297099
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein expression in ovarian cancer cell line following treatment with cisplatin.
Yang X; Pagé M
Oncol Res; 1995; 7(12):619-24. PubMed ID: 8704279
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of sulofenur and a second generation diarylsulfonylurea, N-[5-(2,3-dihydrobenzofuryl)sulfonyl]-N'-(3,4-dichlorophenyl)urea (LY295501), against colon adenocarcinoma xenografts.
Houghton PJ; Cheshire PJ; Myers L; Lutz L; Toth J; Grindey GB; Houghton JA
Anticancer Drugs; 1995 Apr; 6(2):317-23. PubMed ID: 7795279
[TBL] [Abstract][Full Text] [Related]
11. Effects of diarylsulfonylurea antitumor agents on the function of mitochondria isolated from rat liver and GC3/c1 cells.
Rush GF; Rinzel S; Boder G; Heim RA; Toth JE; Ponsler GD
Biochem Pharmacol; 1992 Dec; 44(12):2387-94. PubMed ID: 1472104
[TBL] [Abstract][Full Text] [Related]
12. Atypical multi-drug resistance (MDR): low sensitivity of a P-glycoprotein-expressing human T lymphoblastoid MDR cell line to classical P-glycoprotein-directed resistance-modulating agents.
Jachez B; Loor F
Anticancer Drugs; 1993 Dec; 4(6):605-15. PubMed ID: 7905300
[TBL] [Abstract][Full Text] [Related]
13. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines.
Slovak ML; Hoeltge GA; Dalton WS; Trent JM
Cancer Res; 1988 May; 48(10):2793-7. PubMed ID: 2896069
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
[TBL] [Abstract][Full Text] [Related]
16. Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance.
Ho SB; Yan PS; Dahiya R; Neuschwander-Tetri BA; Basbaum C; Kim YS
J Cell Physiol; 1994 Aug; 160(2):213-26. PubMed ID: 7913708
[TBL] [Abstract][Full Text] [Related]
17. Influence of extracellular pH on the accumulation and cytotoxicity of N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl)urea in human cell lines.
Sosinski J; Chapin C; Thakar JH; Houghton PJ
Cancer Commun; 1991; 3(12):373-81. PubMed ID: 16296003
[TBL] [Abstract][Full Text] [Related]
18. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
19. Characterization of 2-chloro-N10-substituted phenoxazines for reversing multidrug resistance in cancer cells.
Thimmaiah KN; Jayashree BS; Germain GS; Houghton PJ; Horton JK
Oncol Res; 1998; 10(1):29-41. PubMed ID: 9613455
[TBL] [Abstract][Full Text] [Related]
20. Binding of an optically pure photoaffinity analogue of verapamil, LU-49888, to P-glycoprotein from multidrug-resistant human leukemic cell lines.
Qian XD; Beck WT
Cancer Res; 1990 Feb; 50(4):1132-7. PubMed ID: 1967551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
